A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects

Shao-Jun Zhao; De-Hua Wang; Yan-Wei Li; Lei Han; Xing Xiao; Min Ma; David Chi-Cheong Wan; An Hong; Yi Ma

doi:10.2147/IJN.S130566

open access to scientific and medical research

Back to Journals » International Journal of Nanomedicine » Volume 12

Original Research

A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects

Total article views		HTML views	PDF downloads	Totals
8,277	Dovepress*	7,401+	1,402	8,803
	PubMed Central*	876	290	1,166
	Totals	8,277	1,692	9,969
*Since 20 March 2017

View citations on PubMed Central and Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.